{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:21:45Z","timestamp":1773922905585,"version":"3.50.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"DOI":"10.13039\/501100007427","name":"Research Institute for Endocrine Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007427","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Reprod."],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1093\/humrep\/dew071","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T00:28:35Z","timestamp":1460593715000},"page":"1339-1346","source":"Crossref","is-referenced-by-count":5,"title":["Does the risk of metabolic disorders increase among women with polycystic ovary morphology? A population-based study"],"prefix":"10.1093","volume":"31","author":[{"given":"M.","family":"Bahri Khomami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ramezani Tehrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,4,12]]},"reference":[{"key":"2016051808080041000_31.6.1339.1","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2003-031600","article-title":"Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome","volume":"9","author":"Adams","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2016051808080041000_31.6.1339.2","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"16","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"2016051808080041000_31.6.1339.3","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"7","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2016051808080041000_31.6.1339.4","first-page":"243","article-title":"Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity","volume":"3","author":"Azizi","year":"2010","journal-title":"Arch Iran Med"},{"key":"2016051808080041000_31.6.1339.5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome","volume":"4","author":"Barber","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2016051808080041000_31.6.1339.6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.fertnstert.2008.05.018","article-title":"Cardiovascular risk in normal weight, eumenorrheic, nonhirsute daughters of patients with polycystic ovary syndrome: a pilot study","volume":"1","author":"Battaglia","year":"2009","journal-title":"Fertil Steril"},{"key":"2016051808080041000_31.6.1339.7","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1210\/jc.2004-2279","article-title":"Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters","volume":"5","author":"Carmina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2016051808080041000_31.6.1339.8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/uog.11202","article-title":"Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?","volume":"2","author":"Catteau-Jonard","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2016051808080041000_31.6.1339.9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/09513590312331290278","article-title":"Insulin resistance and lipid profile in women with polycystic appearing ovaries: implications with regard to polycystic ovary syndrome","volume":"5","author":"Cenk Sayin","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"2016051808080041000_31.6.1339.10","first-page":"995","article-title":"Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing","volume":"3","author":"Chang","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2016051808080041000_31.6.1339.11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"3","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2016051808080041000_31.6.1339.12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"7","author":"Diamanti-Kandarakis E","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"2016051808080041000_31.6.1339.13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/09513590600630447","article-title":"Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?","volume":"6","author":"Engin-Ustun","year":"2006","journal-title":"Gynecol Endocrinol"},{"key":"2016051808080041000_31.6.1339.14","unstructured":"Evidence-based Methodology Workshop on Polycystic Ovary Syndrome: Final Report. NIH, 2012."},{"key":"2016051808080041000_31.6.1339.15","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1530\/EJE-14-0295","article-title":"Mechanisms in endocrinology: thyroid and polycystic ovary syndrome","volume":"1","author":"Gaberscek","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2016051808080041000_31.6.1339.16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.fertnstert.2009.04.021","article-title":"Not all women diagnosed with PCOS share the same cardiovascular risk profiles","volume":"3","author":"Jovanovic","year":"2010","journal-title":"Fertil Steril"},{"key":"2016051808080041000_31.6.1339.17","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"9","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2016051808080041000_31.6.1339.18","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/jc.2004-0219","article-title":"Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype","volume":"5","author":"Legro","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2016051808080041000_31.6.1339.19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0015-0282(00)00695-6","article-title":"Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?","volume":"3","author":"Loucks","year":"2000","journal-title":"Fertil Steril"},{"key":"2016051808080041000_31.6.1339.20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.1999.00886.x","article-title":"Polycystic ovaries and associated clinical and biochemical features in young women","volume":"6","author":"Michelmore","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2016051808080041000_31.6.1339.21","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1210\/jc.2008-2771","article-title":"Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population","volume":"5","author":"Mortensen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2016051808080041000_31.6.1339.22","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1210\/jc.2006-1085","article-title":"Polycystic ovarian morphology in normal women does not predict the development of polycystic ovary syndrome","volume":"10","author":"Murphy","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2016051808080041000_31.6.1339.23","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/oxfordjournals.humrep.a136280","article-title":"Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome","volume":"9","author":"Norman","year":"1995","journal-title":"Hum Reprod"},{"key":"2016051808080041000_31.6.1339.24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejogrb.2013.12.018","article-title":"To what extent does the use of the Rotterdam criteria affect the prevalence of polycystic ovary syndrome? A community-based study from the Southwest of Iran","volume":"12","author":"Rashidi","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2016051808080041000_31.6.1339.25","first-page":"41","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"1","year":"2004","journal-title":"Hum Reprod"},{"key":"2016051808080041000_31.6.1339.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(15)30642-6"},{"key":"2016051808080041000_31.6.1339.27","first-page":"3015","article-title":"Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)","volume":"23","year":"1993","journal-title":"JAMA"},{"key":"2016051808080041000_31.6.1339.28","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.fertnstert.2013.11.027","article-title":"Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome","volume":"3","author":"Sung","year":"2014","journal-title":"Fertil Steril"},{"key":"2016051808080041000_31.6.1339.29","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-41"},{"key":"2016051808080041000_31.6.1339.30","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-9-39"},{"key":"2016051808080041000_31.6.1339.31","doi-asserted-by":"crossref","unstructured":"Yetkin DO , Dogantekin B . The lipid parameters and lipoprotein(a) excess in Hashimoto thyroiditis. Int J Endocrinol 2015;952729.","DOI":"10.1155\/2015\/952729"},{"key":"2016051808080041000_31.6.1339.32","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"10","author":"Yildiz","year":"2012","journal-title":"Hum Reprod"},{"key":"2016051808080041000_31.6.1339.33","doi-asserted-by":"publisher","DOI":"10.1186\/1758-5996-3-18"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/31\/6\/1339\/17373326\/dew071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T18:18:10Z","timestamp":1718475490000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/dew071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,12]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,5,18]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1093\/humrep\/dew071"],"URL":"https:\/\/doi.org\/10.1093\/humrep\/dew071","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,12]]}}}